Review decisions
Showing 10 results of 13 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1716577628323
Product Type: Drug
Control Number: 262892
DIN(s): 02489783, 02530031
Manufacturer: GlaxoSmithKline Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-03-30
Decision / Authorization Date: 2024-01-12
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1697728420996
Product Type: Drug
Control Number: 265427
DIN(s): 02475200, 02475219
Manufacturer: AstraZeneca Canada Inc
Submission Type: Supplement to a New Drug Submission - Notice of Compliance with Conditions
Date Filed / Submission Date: 2022-06-22
Decision / Authorization Date: 2023-07-11
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00999
Product Type: Drug
Control Number: 259448
DIN(s): 02530031
Manufacturer: GlaxoSmithKline Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-11-10
Decision / Authorization Date: 2022-08-24
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00989
Product Type: Drug
Control Number: 259417
Manufacturer: AstraZeneca Canada Inc.
Submission Type: Supplement to a New Drug Submission - Notice of Compliance with Conditions
Date Filed / Submission Date: 2021-12-09
Decision / Authorization Date: 2022-07-27
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00813
Product Type: Drug
Control Number: 227804
DIN(s): 02503603
Manufacturer: Eckert & Ziegler Radiopharma GmbH
Submission Type: New Drug Submission
Date Filed / Submission Date: 2019-05-15
Decision / Authorization Date: 2020-08-19
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00465
Product Type: Drug
Control Number: 221824
DIN(s): 02492806
Manufacturer: IRE ELiT S.A.
Submission Type: New Drug Submission
Issued / Original Publication Date: 2020-03-09
Updated Date: 2022-11-04
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00657
Product Type: Drug
Control Number: 216792
DIN(s): 02489783
Manufacturer: GlaxoSmithKline Canada Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2018-06-04
Decision / Authorization Date: 2019-06-27
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00506
Product Type: Drug
Control Number: 227804
DIN(s): 02503603
Manufacturer: Eckert & Ziegler Radiopharma GmbH
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2019-05-15
Issued / Original Publication Date: 2020-11-25
Decision / Authorization Date: 2020-08-19
Updated Date: 2024-11-20
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00450
Product Type: Drug
Control Number: 216792
DIN(s): 02489783, 02530031
Manufacturer: GlaxoSmithKline Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2018-06-04
Issued / Original Publication Date: 2019-11-19
Decision / Authorization Date: 2019-06-27
Updated Date: 2025-08-20
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00399
Product Type: Drug
Control Number: 210204
Manufacturer: AstraZeneca Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2017-10-13
Decision / Authorization Date: 2018-05-08